UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 9 Issue 6
June-2022
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2206171


Registration ID:
403818

Page Number

b516-b541

Share This Article


Jetir RMS

Title

Design,Development and Characterization of orally disintegrating tablet for enhancing patient compliance

Abstract

An Orally disintegrating tablet disperses readily in saliva and the drug is available in solution or suspension form for the immediate absorption and resulting in rapid onset of action. In the present research work Modafinil Orally disintegrating tablet were prepared by wet granulation method using varying concentrations of Lycoat, Crosspovidone & Sodium alginate as superdisintegrants. The formulations prepared were evaluated for precompression & post compression parameters. Form the drug excipient compatibility studies we observe that there are no interactions between the pure drug (Modafinil) and optimized formulation (Modafinil+ excipients) which indicates there are no physical changes. Post compression parameters was found to be within the limits. Among the formulation prepared the tablet containing concentration of Crosspovidone shows 99.18% of the drug release within 10 min, 28 sec Disintegration time & follows first order kinetics. The overall result indicated that the formulation F8 containing Crosspovidone is better and fulfilling of the needs of the Orally disintegrating tablet.

Key Words

Orally disintegrating tablet, Modafinil, Crosspovidone, Lycoat, superdisintegrant

Cite This Article

"Design,Development and Characterization of orally disintegrating tablet for enhancing patient compliance", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 6, page no.b516-b541, June-2022, Available :http://www.jetir.org/papers/JETIR2206171.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Design,Development and Characterization of orally disintegrating tablet for enhancing patient compliance", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 6, page no. ppb516-b541, June-2022, Available at : http://www.jetir.org/papers/JETIR2206171.pdf

Publication Details

Published Paper ID: JETIR2206171
Registration ID: 403818
Published In: Volume 9 | Issue 6 | Year June-2022
DOI (Digital Object Identifier):
Page No: b516-b541
Country: Parbhani, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000219

Print This Page

Current Call For Paper

Jetir RMS